La Jolla Pharmaceutical won FDA approval Thursday for Giapreza, a drug that treats dangerously low blood pressure in adults with septic or other distributive shock. Here are three things to know. 1.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback